Online citations, reference lists, and bibliographies.
← Back to Search

Comparative Effects Of An Elemental And A Complex Enteral Feeding Formulation On The Absorption Of Phenytoin Suspension.

M. Marvel, J. Bertino
Published 1991 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The effect of an elemental formula (Vivonex TEN) and a lactose-free complex formula (Ensure) on the oral absorption of a single dose of phenytoin suspension was determined in 10 normal volunteers. Following an overnight fast, subjects were randomly administered 400 mg of phenytoin suspension alone, phenytoin plus Vivonex TEN (unflavored), and phenytoin plus Ensure. The enteral feedings were given every 4 hours throughout the first 24 hours. Serum phenytoin concentrations were obtained over the 72-hour period following drug administration. No statistical difference in area under the curve (AUC), time to peak phenytoin concentration, or peak phenytoin concentration was observed during the three treatment phases. These data suggest that the two enteral feeding formulations investigated do not interfere with nor enhance or accelerate phenytoin absorption as determined by a single-dose study.
This paper references



This paper is referenced by
Pediatric Critical Care Nutrition
P. Goday (2014)
To Hold (Enteral Feeding) or Not to Hold: That IS the Question; A Commentary and Tutorial
C. Parrish (2012)
10.1097/FTD.0b013e3181d3fa3e
Phenytoin Blood Concentrations in Hospitalized Geriatric Patients: Oral Versus Nasogastric Feeding Tube Administration
E. Lubart (2010)
10.1007/978-1-60327-362-6_20
Drug-nutrient interactions in infancy and childhood.
Laureen Murphy Kotzer (2009)
10.1007/978-1-60327-362-6_22
Drug–Nutrient Interactions in the Elderly
B. Kinosian (2009)
10.1007/978-1-60327-362-6_13
Drug–Nutrient Interactions in Patients Receiving Enteral Nutrition
C. Rollins (2009)
10.1016/j.curtheres.2007.10.007
Steady-state serum phenytoin concentrations after nasogastric tube administration of immediate-release phenytoin tablets and extended-release phenytoin capsules: an open-label, crossover, clinical trial.
D. Panomvana (2007)
10.1177/0115426505020006618
Enteral nutrition and drug administration, interactions, and complications.
B. Magnuson (2005)
10.1007/BF01871260
Phenytoin pharmacokinetics after intravenous administration to patients receiving enteral tube feeding
Cameron T. C. Randall (2005)
10.1108/NFS.2011.41.6.448.1
Handbook of drug-nutrient interactions.
J. Boullata (2004)
10.1177/001857870403900111
Medication Administration Considerations for Patients Receiving Enteral Tube Feedings
R. Dickerson (2004)
10.1345/aph.19355
Phenytoin and Enteral Feedings: Does Evidence Support an Interaction?
S. A. Yeung (2000)
10.1097/00044067-200011000-00009
Drug-nutrient interactions: a review.
D. Maka (2000)
10.1002/j.1875-9114.1998.tb03128.x
Bioavailability of Phenytoin Acid and Phenytoin Sodium with Enteral Feedings
K. K. Doak (1998)
10.1177/0115426596011004175
Is the phenytoin-enteral feeding formula interaction a myth?
J. Bertino (1996)
10.1097/00000446-199703000-00027
Critical Care Nursing of Infants and Children
M. Curley (1996)
10.1016/0016-5085(95)90231-7
American Gastroenterological Association technical review on tube feeding for enteral nutrition.
D. F. Kirby (1995)
10.1177/014860719201600195
Phenytoin and enteral feeding.
P. A. Mohler (1992)
10.1177/014860719201600131
Response to Dr Mohler's Letter
J. S. Bertino (1992)
Potential Nasoenteric Tube Complications Arrhythmia Empyema Gastric perforation Myocardial infarction Otitis media Pulmonary intubation Rupture and leakage of mercury weight Tube feeding into pulmonary tree Clogging Epistaxsis Gastrointestinal bleeding Nasal mucosal ulceration Pneumothorax Pyriform
()
Semantic Scholar Logo Some data provided by SemanticScholar